SCHEMBL7410702

SCHEMBL7410702

COc1ccc(S(=O)(=O)NC(CC(=O)NO)c2ccccc2)cc1

nearest known ligand 0.67

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 8/20 0.67
PDE4B Q07343 8/20 0.67
PDE4C Q08493 8/20 0.67
PDE4D Q08499 8/20 0.67
MMP2 P08253 7/20 0.67
MMP3 P08254 7/20 0.67
MMP1 P03956 5/20 0.63
ALDH1A1 P00352 3/20 0.62
ATM Q13315 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
KDM4E B2RXH2 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C19 P33261 1/20 0.53
MEP1B Q16820 1/20 0.52
EEF2K O00418 2/20 0.52
KCNA5 P22460 1/20 0.52
TP53 P04637 1/20 0.52
POLB P06746 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7419745 0.86 MMP1 (0.59) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL2454202 0.85 MMP9 (0.58) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7418486 0.85 ATM (0.57) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7416702 0.81 MEP1B (0.58) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL6823156 0.80 MMP2 (1.00) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7461425 0.80 MEP1B (0.56) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7373322 0.79 MMP9 (0.57) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL7373320 0.79 MMP9 (0.57) PDE4APDE4BPDE4CPDE4DMMP2
SCHEMBL29183283 0.78 ALDH1A1 (0.55) ALDH1A1ATML3MBTL1KDM4ECYP3A4
SCHEMBL7383649 0.77 SLC1A3 (0.59) PDE4APDE4BPDE4CPDE4DMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6218389-B1 FOR THERAPY AND PROPHYLAXIS OF ARTHRITIS, CANCER, CARDIOVASCULAR DISORDERS; SKIN DISORDERS; OCULAR DISORDERS; INFLAMMATION AND GUM DISEASES, MULTIPLE SCLEROSIS, CACHEXIA, PREVENTING LOOSENING OF PROSTHETIC DEVICES THE PROCTER & GAMBLE CO. 2001-04-17 US disclosed
EP-1009737-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 2000-06-21 EP disclosed
WO-1999006340-A2 SULFONYLAMINO SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS METALLOPROTEASE INHIBITORS THE PROCTER & GAMBLE COMPANY (US) 1999-02-11 WO disclosed